Interest in artificial intelligence (AI) solutions for new medication development is exploding and fueled by pressures to reduce the time and cost it takes to bring new drugs to market. Also stoking the trend are advances in AI technology and computer processing speed, in addition to the abundance of available data that feed AI models.
In this report, we explore developments and debates in AI-based drug development with first-person insights from the AlphaSense expert transcript library, your single-source solution for quality expert perspectives.
Download our report now to learn what industry experts say about how AI is reshaping the drug development landscape.